Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC).
Strike Pharma has raised $4.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2022.
Strike Pharma's investors include Almi Invest, EIR Ventures, Flerie Invest.
Strike Pharma is headquartered in Uppsala, Sweden.
Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC).
Strike Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Strike Pharma — Funding & Investors." VCBacked, February 22, 2022, https://www.vcbacked.co/company/strike-pharma. Accessed August 14, 2026.
VCBacked. (2022). Strike Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/strike-pharma
{{cite web |title=Strike Pharma — Funding & Investors |url=https://www.vcbacked.co/company/strike-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated